Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Aileron's Staple Peptide targets a novel interaction site for BAX activation

Dec. 23, 2008

Medivation completes enrollment in phase I/II trial of MDV-3100 in prostate cancer

Dec. 22, 2008

Cell Therapeutics and Spectrum form joint venture to market Zevalin in the U.S.

Dec. 22, 2008

Merrimack reports preclinical efficacy for novel MM-111 antibody in experimental cancer models

Dec. 22, 2008

Darinaparsin demonstrates activity, tolerability in advanced lymphomas

Dec. 22, 2008

EntreMed focuses resources on development of ENMD-2076

Dec. 19, 2008

Synta earns USD 15 million in milestone payments from GSK for development of elesclomol

Dec. 19, 2008

Delcath enrolls 50% of patients in metastatic melanoma phase III clinical trial of PHP system

Dec. 19, 2008

Clinical data show efficacy for bosutinib in chronic myelogenous leukemia

Dec. 19, 2008

Evidence of pharmacodynamic activity seen for triciribine in phase I trial

Dec. 19, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...